Mucin-type O-glycans and their roles in intestinal homeostasis

Glycobiology

Volumn 23, Issue 9, 2013, Pages 1026-1037

  Bergstrom, Kirk S B ^a   Xia, Lijun ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Colitis; Intestinal homeostasis; Microbiota; Mucin; Mucintype O glycans

Indexed keywords

MUCIN; MUCIN 1; MUCIN 12; MUCIN 13; MUCIN 2; MUCIN 3; MUCIN 4; MUCIN 5AC; MUCIN 5B; UNCLASSIFIED DRUG;

COLITIS; GLYCOSYLATION; HOMEOSTASIS; INTESTINAL HOMEOSTASIS; INTESTINE FLORA; MICROFLORA; MUCUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SYMBIOSIS;

COLITIS; INTESTINAL HOMEOSTASIS; MICROBIOTA; MUCIN; MUCIN-TYPE O-GLYCANS;

HOMEOSTASIS; HUMANS; INTESTINES; MUCINS; POLYSACCHARIDES;

EID: 84880962090     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwt045     Document Type: Review

References (116)

1. Allen A, Hutton DA, Pearson JP. 1998. The MUC2 gene product: A human intestinal mucin. Int J Biochem Cell B. 30: 797-801.
2. An G, Wei B, Xia B, McDaniel JM, Ju T, Cummings RD, Braun J, Xia L. 2007. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med. 204: 1417-1429.
3. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende D, Fernandes G, Tap J, Bruls T, Batto J, et al. 2011. Enterotypes of the human gut microbiome. Nature. 473: 174-180.
4. Asker N, Axelsson MA, Olofsson SO, Hansson GC. 1998. Dimerization of the human MUC2 mucin in the endoplasmic reticulum is followed by a N-glycosylation-dependent transfer of the mono- and dimers to the Golgi apparatus. J Biol Chem. 273: 18857-18863.
5. Atuma C, Strugala V, Allen A, Holm L. 2001. The adherent gastrointestinal mucus gel layer: Thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol. 280: G922-G929.
6. Axelsson MA, Karlsson NG, Steel DM, Ouwendijk J, Nilsson T, Hansson GC. 2001. Neutralization of pH in the Golgi apparatus causes redistribution of glycosyltransferases and changes in the O-glycosylation of mucins. Glycobiology. 11: 633-644.
7. Backstrom M, Ambort D, Thomsson E, Johansson ME, Hansson GC. 2013. Increased understanding of the biochemistry and biosynthesis of MUC2 and other gel-forming mucins through the recombinant expression of their protein domains. Mol Biotechnol. 54(2): 250-256.
8. Bafna S, Kaur S, Batra SK. 2010. Membrane-bound mucins: The mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 29: 2893-2904.
9. Barrow H, Tam B, Duckworth CA, Rhodes JM, Yu LG. 2013. Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and core 3 glycans in human colon cancer cells. PLoS One. 8: e59792.
10. Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. 2012. Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family. Glycobiology. 22: 736-756.
11. Bierhuizen MF, Fukuda M. 1992. Expression cloning of a cDNA encoding UDP-GlcNAc: Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. Proc Natl Acad Sci USA. 89: 9326-9330.
12. Brockhausen I. 2007. Biosynthesis of mucin-type O-glycans. In: Johannis PK, editor. Comprehensive Glycoscience. Oxford: Elsevier. p. 33-59.
13. Brockhausen I, Schachter H, Stanley P. 2009. O-GalNAc glycans. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Essentials of Glycobiology. 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press. Chapter 9. p. 115-128.
14. Byrd J, Bresalier R. 2004. Mucins and mucin binding proteins in colorectal cancer. Cancer Metast Rev. 23: 77-99.
15. Cash HL, Whitham CV, Behrendt CL, Hooper LV. 2006. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 313: 1126-1130.
16. Chang DE, Smalley DJ, Tucker DL, Leatham MP, Norris WE, Stevenson SJ, Anderson AB, Grissom JE, Laux DC, Cohen PS, et al. 2004. Carbon nutrition of Escherichia coli in the mouse intestine. Proc Natl Acad Sci USA. 101: 7427-7432.
17. Comstock LE. 2009. Importance of glycans to the host-bacteroides mutualism in the mammalian intestine. Cell Host Microbe. 5: 522-526.
18. Corfield AP, Wagner SA, Clamp JR, Kriaris MS, Hoskins LC. 1992. Mucin degradation in the human colon: Production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect Immun. 60: 3971-3978.
19. Coyne MJ, Chatzidaki-Livanis M, Paoletti LC, Comstock LE. 2008. Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilis. Proc Natl Acad Sci USA. 105: 13099-13104.
20. Coyne MJ, Reinap B, Lee MM, Comstock LE. 2005. Human symbionts use a host-like pathway for surface fucosylation. Science. 307: 1778-1781.
21. Croix JA, Carbonero F, Nava GM, Russell M, Greenberg E, Gaskins HR. 2011. On the relationship between sialomucin and sulfomucin expression and hydrogenotrophic microbes in the human colonic mucosa. PLoS One. 6: e24447.
22. Dawson PA, Huxley S, Gardiner B, Tran T, McAuley JL, Grimmond S, McGuckin MA, Markovich D. 2009. Reduced mucin sulfonation and impaired intestinal barrier function in the hyposulfataemic NaS1 null mouse. Gut. 58: 910-919.
23. Derrien M, Collado MC, Ben-Amor K, Salminen S, de Vos WM. 2008. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol. 74: 1646-1648.
24. Duck LW, Walter MR, Novak J, Kelly D, Tomasi M, Cong Y, Elson CO. 2007. Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm Bowel Dis. 13: 1191-1201.
25. Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, Goulding D, O'Connell Motherway M, Shanahan F, Nally K, Dougan G, et al. 2012. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci USA. 109: 2108-2113.
26. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, Caderni G. 2002. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethaneinduced colon carcinogenesis in rats. Carcinogenesis. 23: 1953-1960.
27. Fu J, Wei B, Wen T, Johansson ME, Liu X, Bradford E, Thomsson KA, McGee S, Mansour L, Tong M, et al. 2011. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest. 121: 1657-1666.
28. Fujita K, Oura F, Nagamine N, Katayama T, Hiratake J, Sakata K, Kumagai H, Yamamoto K. 2005. Identification and molecular cloning of a novel glycoside hydrolase family of core 1 type O-glycan-specific endo-α-N- acetylgalactosaminidase from Bifidobacterium longum. J Biol Chem. 280: 37415-37422.
29. Godl K, Johansson ME, Lidell ME, Morgelin M, Karlsson H, Olson FJ, Gum JR, Jr, Kim YS, Hansson GC. 2002. The N terminus of the MUC2 mucin forms trimers that are held together within a trypsin-resistant core fragment. J Biol Chem. 277: 47248-47256.
30. Hemmerich S, Leffler H, Rosen SD. 1995. Structure of the O-glycans in GlyCAM-1, an endothelial-derived ligand for L-selectin. J Biol Chem. 270: 12035-12047.
31. Hooper LV, Gordon JI. 2001. Glycans as legislators of host-microbial interactions: Spanning the spectrum from symbiosis to pathogenicity. Glycobiology. 11: 1R-10R.
32. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. 2003. Angiogenins: A new class of microbicidal proteins involved in innate immunity. Nat Immunol. 4: 269-273.
33. Hooper LV, Xu J, Falk PG, Midtvedt T, Gordon JI. 1999. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci USA. 96: 9833-9838.
34. Hoskins L, Agustines M, McKee W, Boulding E, Kriaris M, Niedermeyer G. 1985. Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins. J Clin Invest. 75: 944-953.
35. Huang JY, Lee SM, Mazmanian SK. 2011. The human commensal Bacteroides fragilis binds intestinal mucin. Anaerobe. 17: 137-141.
36. Hurd EA, Holmen JM, Hansson GC, Domino SE. 2005. Gastrointestinal mucins of Fut2-null mice lack terminal fucosylation without affecting colonization by Candida albicans. Glycobiology. 15: 1002-1007.
37. Ikehara Y, Nishihara S, Yasutomi H, Kitamura T, Matsuo K, Shimizu N, Inada K-I, Kodera Y, Yamamura Y, Narimatsu H, et al. 2001. Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidem Biomar. 10: 971-977.
38. Iwai T, Inaba N, Naundorf A, Zhang Y, Gotoh M, Iwasaki H, Kudo T, Togayachi A, Ishizuka Y, Nakanishi H, et al. 2002. Molecular cloning and characterization of a novel UDP-GlcNAc: GalNAc-peptide beta1, 3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans. J Biol Chem. 277: 12802-12809.
39. Iwai T, Kudo T, Kawamoto R, Kubota T, Togayachi A, Hiruma T, Okada T, Kawamoto T, Morozumi K, Narimatsu H. 2005. Core 3 synthase is downregulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc Natl Acad Sci USA. 102: 4572-4577.
40. Iwamori M, Domino SE. 2004. Tissue-specific loss of fucosylated glycolipids in mice with targeted deletion of alpha(1, 2)fucosyltransferase genes. Biochem J. 380: 75-81.
41. Johansson ME, Ambort D, Pelaseyed T, Schutte A, Gustafsson JK, Ermund A, Subramani DB, Holmen-Larsson JM, Thomsson KA, Bergstrom JH, et al. 2011. Composition and functional role of the mucus layers in the intestine. Cell Mol Life Sci. 68: 3635-3641.
42. Johansson MEV, Gustafsson JK, Holmen-Larsson J, Jabbar KS, Xia L, Xu H, Ghishan FK, Carvalho FA, Gewirtz AT, Sjovall H, et al. 2013. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. doi: 10.1136/gutjnl-2012-303207.
43. Johansson ME, Gustafsson JK, Sjoberg KE, Petersson J, Holm L, Sjovall H, Hansson GC. 2010. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One. 5: e12238.
44. Johansson ME, Holmen Larsson JM, Hansson GC. 2011. Microbes and Health Sackler Colloquium: The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci USA. 108 Suppl 1: 4659-4665.
45. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. 2008. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA. 105: 15064-15069.
46. Johansson ME, Sjovall H, Hansson GC. 2013. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol., doi: 10.1038/nrgastro.2013.35.
47. Johansson MEV, Thomsson KA, Hansson GC. 2009. Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein. J Proteome Res. 8: 3549-3557.
48. Ju T, Cummings RD. 2002. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci USA. 99: 16613-16618.
49. Ju T, Cummings RD, Canfield WM. 2002. Purification, characterization, and subunit structure of rat core 1 Beta1, 3-galactosyltransferase. J Biol Chem. 277: 169-177.
50. Kamada N, Kim Y-G, Sham HP, Vallance BA, Puente JL, Martens EC, Nunez G. 2012. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science. 336: 1325-1329.
51. Katayama T, Sakuma A, Kimura T, Makimura Y, Hiratake J, Sakata K, Yamanoi T, Kumagai H, Yamamoto K. 2004. Molecular cloning and characterization of Bifidobacterium bifidum 1, 2-α-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J Bacteriol. 186: 4885-4893.
52. Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda MN, Fukuda M, Katsuyama T, Nakayama J. 2004. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science. 305: 1003-1006.
53. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S. 2004. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol. 5: 104-112.
54. Kinoshita H, Wakahara N, Watanabe M, Kawasaki T, Matsuo H, Kawai Y, Kitazawa H, Ohnuma S, Miura K, Horii A, et al. 2008. Cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Lactobacillus plantarum LA 318 recognizes human A and B blood group antigens. Res Microbiol. 159: 685-691.
55. Kobayashi M, Lee H, Nakayama J, Fukuda M. 2009. Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection. Curr Drug Metab. 10: 29-40.
56. Larsson JM, Karlsson H, Crespo JG, Johansson ME, Eklund L, Sjovall H, Hansson GC. 2011. Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm Bowel Dis. 17: 2299-2307.
57. Leatham MP, Banerjee S, Autieri SM, Mercado-Lubo R, Conway T, Cohen PS. 2009. Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157: H7 growth in the streptomycin-treated mouse intestine. Infect Immun. 77: 2876-2886.
58. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R, et al. 2008. Evolution of mammals and their gut microbes. Science. 320: 1647-1651.
59. Lievin-Le Moal V, Servin AL. 2006. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: Mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev. 19: 315-337.
60. Liu CH, Lee SM, Vanlare JM, Kasper DL, Mazmanian SK. 2008. Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc Natl Acad Sci USA. 105: 3951-3956.
61. Macpherson AJ, Geuking MB, McCoy KD. 2012. Homeland security: IgA immunity at the frontiers of the body. Trends Immunol. 33: 160-167.
62. Magalhaes A, Gomes J, Ismail MN, Haslam SM, Mendes N, Osorio H, David L, Le Pendu J, Haas R, Dell A, et al. 2009. Fut2-null mice display an altered glycosylation profile and impaired BabA-mediated Helicobacter pylori adhesion to gastric mucosa. Glycobiology. 19: 1525-1536.
63. Magnet AD, Fukuda M. 1997. Expression of the large I antigen forming beta-1, 6-N-acetylglucosaminyltransferase in various tissues of adult mice. Glycobiology. 7: 285-295.
64. Makivuokko H, Lahtinen S, Wacklin P, Tuovinen E, Tenkanen H, Nikkila J, Bjorklund M, Aranko K, Ouwehand A, Matto J. 2012. Association between the ABO blood group and the human intestinal microbiota composition. BMC Microbiol. 12: 94.
65. Maltby R, Leatham-Jensen MP, Gibson T, Cohen PS, Conway T. 2013. Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157: H7 in the mouse intestine. PLoS One. 8: e53957.
66. Manichanh C, Borruel N, Casellas F, Guarner F. 2012. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 9: 599-608.
67. Martens EC, Chiang HC, Gordon JI. 2008. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe. 4: 447-457.
68. Martens EC, Roth R, Heuser JE, Gordon JI. 2009a. Coordinate regulation of glycan degradation and polysaccharide capsule biosynthesis by a prominent human gut symbiont. J Biol Chem. 284: 18445-18457.
69. Martens EC, Roth R, Heuser JE, Gordon JI. 2009b. Coordinate regulation of glycan degradation and polysaccharide capsule biosynthesis by a prominent human gut symbiont. J Biol Chem. 284: 18445-18457.
70. Mazmanian SK, Round JL, Kasper DL. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 453: 620-625.
71. McGovern DPB, Jones MR, Taylor KD, Marciante K, Yan X, Dubinsky M, Ippoliti A, Vasiliauskas E, Berel D, Derkowski C, et al. 2010. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet. 19: 3468-3476.
72. McGuckin MA, Lindën SK, Sutton P, Florin TH. 2011. Mucin dynamics and enteric pathogens. Nat Rev Micro. 9: 265-278.
73. Meng D, Newburg DS, Young C, Baker A, Tonkonogy SL, Sartor RB, Walker WA, Nanthakumar NN. 2007. Bacterial symbionts induce a FUT2-dependent fucosylated niche on colonic epithelium via ERK and JNK signaling. Am J Physiol Gastrointest Liver Physiol. 293: G780-G787.
74. Meyer-Hoffert U, Hornef MW, Henriques-Normark B, Axelsson LG, Midtvedt T, Putsep K, Andersson M. 2008. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut. 57: 764-771.
75. Nieuw Amerongen AV, Bolscher JG, Bloemena E, Veerman EC. 1998. Sulfomucins in the human body. Biol Chem. 379: 1-18.
76. O'Hara AM, Shanahan F. 2006. The gut flora as a forgotten organ. EMBO Rep. 7: 688-693.
77. Ouellette AJ. 2010. Paneth cells and innate mucosal immunity. Curr Opin Gastroenterol. 26: 547-553.
78. Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ, Corthesy B. 2002. Secretory component: A new role in secretory IgA-mediated immune exclusion in vivo. Immunity. 17: 107-115.
79. Png CW. 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 105: 2420-2428.
80. Podolsky DK, Fournier DA. 1988. Alterations in mucosal content of colonic glycoconjugates in inflammatory bowel disease defined by monoclonal antibodies. Gastroenterology. 95: 379-387.
81. Rausch P, Rehman A, Künzel S, Häsler R, Ott SJ, Schreiber S, Rosenstiel P, Franke A, Baines JF. 2011. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci USA. 108: 19030-19035.
82. Rho JH, Wright DP, Christie DL, Clinch K, Furneaux RH, Roberton AM. 2005. A novel mechanism for desulfation of mucin: Identification and cloning of a mucin-desulfating glycosidase (sulfoglycosidase) from Prevotella strain RS2. J Bacteiol. 187: 1543-1551.
83. Robbe C, Capon C, Coddeville B, Michalski J-C. 2004. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem J. 384: 307-316.
84. Roberton AM, Stanley RA. 1982. In vitro utilization of mucin by Bacteroides fragilis. Appl Environ Microbiol. 43: 325-330.
85. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. 2011. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 332: 974-977.
86. Round JL, Mazmanian SK. 2010. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA. 107: 12204-12209.
87. Ruas-Madiedo P, Gueimonde M, Fernández-García Ma, de los Reyes-Gavilán CG, Margolles A. 2008. Mucin degradation by Bifidobacterium strains isolated from the human intestinal microbiota. Appl Environ Microbiol. 74: 1936-1940.
88. Sartor RB. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology. 134: 577-594.
89. Schwerbrock NM, Makkink MK, van der Sluis M, Buller HA, Einerhand AW, Sartor RB, Dekker J. 2004. Interleukin 10-deficient mice exhibit defective colonic Muc2 synthesis before and after induction of colitis by commensal bacteria. Inflamm Bowel Dis. 10: 811-823.
90. Schwientek T, Yeh JC, Levery SB, Keck B, Merkx G, van Kessel AG, Fukuda M, Clausen H. 2000. Control of O-glycan branch formation. Molecular cloning and characterization of a novel thymus-associated core 2 beta1, 6-n- acetylglucosaminyltransferase. J Biol Chem. 275: 11106-11113.
91. Shen Y, Torchia ML, Lawson GW, Karp CL, Ashwell JD, Mazmanian SK. 2012. Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe. 12: 509-520.
92. Sonnenburg JL. 2005. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science. 307: 1955-1959.
93. Sonnenburg JL, Angenent LT, Gordon JI. 2004. Getting a grip on things: How do communities of bacterial symbionts become established in our intestine? Nat Immunol. 5: 569-573.
94. Spiro RG. 2002. Protein glycosylation: Nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology. 12: 43R-56R.
95. Stappenbeck TS, Hooper LV, Gordon JI. 2002. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA. 99: 15451-15455.
96. Staubach F, Kunzel S, Baines AC, Yee A, McGee BM, Backhed F, Baines JF, Johnsen JM. 2012. Expression of the blood-group-related glycosyltransferase B4galnt2 influences the intestinal microbiota in mice. ISME J. 6: 1345-1355.
97. Stone EL, Ismail MN, Lee SH, Luu Y, Ramirez K, Haslam SM, Ho SB, Dell A, Fukuda M, Marth JD. 2009. Glycosyltransferase function in core 2-type protein O glycosylation. Mol Cell Biol. 29: 3770-3782.
98. Stone EL, Lee SH, Ismail MN, Fukuda M. 2010. Characterization of mice with targeted deletion of the gene encoding core 2 beta1, 6- Nacetylglucosaminyltransferase-2. Methods Enzymol. 479: 155-172.
99. Subramani DB, Johansson ME, Dahlen G, Hansson GC. 2010, Lactobacillus and Bifidobacterium species do not secrete protease that cleaves the MUC2 mucin which organises the colon mucus. Benef Microbes. 1: 343-350.
100. Swidsinski A, Loening-Baucke V, Theissig F, Engelhardt H, Bengmark S, Koch S, Lochs H, Dorffel Y. 2007. Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut. 56: 343-350.
101. Thomsson KA, Holmen-Larsson JM, Angstrom J, Johansson ME, Xia L, Hansson GC. 2012. Detailed O-glycomics of the Muc2 mucin from colon of wild-type, core 1- and core 3-transferase-deficient mice highlights differences compared with human MUC2. Glycobiology. 22: 1128-1139.
102. Thornton DJ, Rousseau K, McGuckin MA. 2008. Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol. 70: 459-486.
103. Tobisawa Y, Imai Y, Fukuda M, Kawashima H. 2010. Sulfation of colonic mucins by N-acetylglucosamine 6-O-sulfotransferase-2 and its protective function in experimental colitis in mice. J Biol Chem. 285: 6750-6760.
104. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. 2009. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 1: 6ra14.
105. Turroni F, Bottacini F, Foroni E, Mulder I, Kim J-H, Zomer A, Sánchez B, Bidossi A, Ferrarini A, Giubellini V, et al. 2010. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci USA. 107: 19514-19519.
106. Turroni F, Milani C, van Sinderen D, Ventura M. 2011. Genetic strategies for mucin metabolism in Bifidobacterium bifidum PRL2010: An example of possible human-microbe co-evolution. Gut Microbes. 2: 183-189.
107. Tytgat KM, van der Wal JW, Einerhand AW, Buller HA, Dekker J. 1996. Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochem Biophys Res Commun. 224: 397-405.
108. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O, Ley R, Wakeland EK, Hooper LV. 2011. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science. 334: 255-258.
109. van der Post S, Subramani DB, Backstrom M, Johansson ME, Vester-Christensen MB, Mandel U, Bennett EP, Clausen H, Dahlen G, Sroka A, et al. 2013. Site-specific O-glycosylation on the MUC2 mucin inhibits cleavage by the Porphyromonas gingivalis secreted cysteine protease (RgpB). J Biol Chem. 10.1074/jbc.M113.459479.
110. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Buller HA, Dekker J, Van Seuningen I, Renes IB, et al. 2006. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 131: 117-129.
111. van Klinken BJ, Einerhand AW, Duits LA, Makkink MK, Tytgat KM, Renes IB, Verburg M, Buller HA, Dekker J. 1999. Gastrointestinal expression and partial cDNA cloning of murine Muc2. Am J Physiol Gastrointest Liver Physiol. 276: G115-G124.
112. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, Kucherlapati R, Lipkin M, Yang K, Augenlicht L. 2002. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 295: 1726-1729.
113. Wacklin P, Makivuokko H, Alakulppi N, Nikkila J, Tenkanen H, Rabina J, Partanen J, Aranko K, Matto J. 2011. Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine. PLoS One. 6: e20113.
114. Wang Y, Ju T, Ding X, Xia B, Wang W, Xia L, He M, Cummings RD. 2010. Cosmc is an essential chaperone for correct protein O-glycosylation. Proc Natl Acad Sci USA. 107: 9228-9233.
115. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science. 334: 105-108.
116. Yeh JC, Ong E, Fukuda M. 1999. Molecular cloning and expression of a novel beta-1, 6-N-acetylglucosaminyltransferase that forms core 2, core 4, and I branches. J Biol Chem. 274: 3215-3221.